Large-Scale mapping of psychotropic weight effects: LLM-Based event detection across 222,545 deduplicated real-world patient narratives
Psychotropic drug-induced weight change is clinically important but remains difficult to compare across large numbers of medications. We analysed 222,545 deduplicated user-generated reviews covering 176 psychotropic medications and acetaminophen as a negative control. A fine-tuned classifier identified reviews describing weight gain, weight loss, or no change, and a Qwen3-8B language model extracted quantified weight changes in kilograms. We derived a Net Weight Effect (NWE), defined as the proportion of reviews describing weight gain minus the proportion describing weight loss (range −1 to +1), and the mean weight change in kilograms, both with bootstrap 95% confidence intervals. Antipsychotics had the highest class-level weight liability (NWE + 0.154; mean +12.6 kg), whereas stimulants showed the most weight-reducing profile (NWE − 0.050; mean −7.1 kg). Olanzapine, mirtazapine, and risperidone ranked highest for weight gain, whereas bupropion/naltrexone and topiramate ranked lowest. Long-term use (>6 months) was associated with a larger mean gain than medium-term use (+8.8 kg vs +2.3 kg), and females reported weight gain more frequently than males. Per-drug rankings were highly concordant across the four source platforms (Kendall’s W = 0.83). In an exploratory receptor-affinity analysis, alpha-2 adrenergic affinity was the strongest correlate of NWE (rho = 0.594; permutation FDR p = 0.006), whereas H1 histamine affinity was the strongest correlate of mean weight change (rho = 0.638; permutation FDR p = 0.042). Large-scale AI-assisted analysis of patient narratives can therefore generate clinically useful real-world rankings of psychotropic weight liability while also highlighting mechanistically plausible, though correlational, pharmacological associations.
Authors
- Julien Godet (ORCID: https://orcid.org/0000-0002-8470-0092)
- Hervé Javelot (ORCID: https://orcid.org/0000-0002-2682-7677)
- Taïoh Yokoyama (ORCID: https://orcid.org/0000-0002-7554-4307)
- Johan H. G. Natter
- Michel Bruno
Institutions
- Centre National de la Recherche Scientifique (FR)
- Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie (FR)
- Observatoire Régional de la Santé d’Alsace (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- Laboratoire de pharmacologie et de toxicologie neurocardiovasculaire (FR)
- Université de Strasbourg (FR)
Publication Details
- Journal
- Translational Psychiatry
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1038/s41398-026-04551-z
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00